Orthopedic medtech company Stryker has had a busy 2025 with new product developments, leadership changes and transactions.
Here are the key headlines:
1. Stryker CFO Glenn Boehnlein is retiring, and Preston Wells will succeed him as vice president and CFO.
2. Stryker was included on Fortune’s annual list of the World’s Most Admired Companies, which was released Jan. 29.
3. Stryker board of directors member Allan Golston plans to retire from his post following 14 years with the company.
4. Stryker completed its acquisition of Inari Medical about a month after announcing the deal in January.
5. Stryker has elevated Kim Montagnino to chief communications officer.
6. Stryker CEO Kevin Lobo’s total compensation grew from $20.8 million in 2023 to just under $22 million in 2024, according to a March 25 Securities and Exchange Commission proxy filing.
7. Investment firm Viscogliosi Brothers completed its acquisition of Stryker’s U.S. spine business. The acquisition was initially announced in January.
8. MemorialCare is the first hospital in the world to complete a robotic hip revision using Stryker’s Mako Total Hip system with 5.0 Advanced Primary and Revision application. It was also the first hospital in California to use the Mako 4 SmartRobotics system in conjunction with Stryker’s Q Guidance System.
9. Stryker plans to absorb the impact of tariffs, an estimated $200 million cost, Vice President and CFO Preston Wells said in a May 1 quarterly earnings call.
10. Stryker’s OptaBlate, the company’s first basivertebral nerve ablation system earned FDA 510(k) clearance.
11. During the second quarter, Stryker reached 2 million procedures with Mako robotics.
12. The company grew its orthopedic sales by 2% during the second quarter.
13. Stryker secured FDA clearance for its Incompass total ankle system to treat patients whose ankle joints have been damaged by severe rheumatoid, post-traumatic or degenerative arthritis.
14. Stryker was included on the 71st Fortune 500, ranking in the top 25 healthcare companies.
15. Stryker introduced new innovations to its nailing and plating platforms. The T2 Alpha Humeral nail will provide surgeons with a new implant that can streamline humeral fixation and support efficient surgical workflows. The company is also working on a novel femur reconstruction fracture system designed for complex femur fractures requiring a dual construct.
16. Stryker’s orthopedic growth has continued through the third quarter, and momentum is expected especially in shoulder care, according to an Oct. 30 earnings call. Read more details here.
17. Stryker appointed Spencer Stiles as president and chief operating officer, effective Jan. 1.
